Evidence map›Paper›PMID 28770232›Full record

ArticleJournal of diabetes research2017

The Association between Type 2 Diabetes Mellitus and Thyroid Cancer.

Young-Gyun Seo, Ho-Chun Choi, Ah Reum An, Do Joon Park, Young Joo Park, Kyu Eun Lee, Sue K Park, Yunji Hwang, Belong Cho

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of diabetes research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Diabetes Mellitus and Thyroid Cancers: Risky Correlation, Underlying Mechanisms and Clinical Prevention.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  8. A machine learning prediction model for cancer risk in patients with type 2 diabetes based on clinical tests.Technology and health care : official journal of the European Society for Engineering and Medicine · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Young-Gyun SeoDepartment of Family Medicine, Hallym University Sacred Heart Hospital, Anyang, Gyeonggi-do 14068, Republic of Korea.ORCID 0000-0001-8294-1741
Ho-Chun ChoiDepartment of Family Medicine, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul 03080, Republic of Korea.ORCID 0000-0002-1427-1288
Ah Reum AnDepartment of Family Medicine, Center for Health Promotion and Optimal Aging, Health Promotion Center for Cancer Survivor, Seoul National University Hospital, Seoul 03080, Republic of Korea.ORCID 0000-0002-2070-430X
Do Joon ParkDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0001-9630-3839
Young Joo ParkDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0002-3671-6364
Kyu Eun LeeDepartment of Surgery, Seoul National University Hospital & College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0002-2354-3599
Sue K ParkDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0001-5002-9707
Yunji HwangDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0001-8598-275X
Belong ChoDepartment of Family Medicine, Center for Health Promotion and Optimal Aging, Health Promotion Center for Cancer Survivor, Seoul National University Hospital, Seoul 03080, Republic of Korea.ORCID 0000-0001-9558-689X
Seoul National University · KRSeoul National University Hospital · KRHallym University Sacred Heart Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe incidence of thyroid cancer is increasing worldwide. The prevalence of type 2 diabetes mellitus (T2DM) is also increasing. Therefore, we aimed to analyze the effect of T2DM on thyroid cancer.

methodsA case-control study was performed. A total of 415 healthy controls with thyroid ultrasound screening and physician consultation were selected from the Thyroid Cancer Longitudinal Study (T-CALOS). Among patients with thyroid cancer who were enrolled in T-CALOS, 415 patients were matched to the control group according to age and sex. We assessed the effects of T2DM, T2DM duration, and T2DM medication on thyroid cancer.

resultsWomen with T2DM had lower odds of thyroid cancer than women without T2DM (odds ratio [OR]: 0.40, 95% confidence interval [CI]: 0.20-0.81). Individuals receiving T2DM medication had higher odds of thyroid cancer compared to those without T2DM medication (OR: 5.21, 95% CI: 1.58-17.15). Individuals with T2DM duration <6 years had lower odds of thyroid cancer compared to those without T2DM (OR: 0.58, 95% CI: 0.34-0.97).

conclusionsIndividuals with early T2DM are presumed to have a low incidence of thyroid cancer, and this effect seems to last up to 6 years after diagnosis of T2DM.

Indexed as

AdultAgedCase-Control StudiesChi-Square DistributionDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsIncidenceLogistic ModelsLongitudinal StudiesMaleMiddle AgedOdds RatioPrevalenceProtective FactorsHypoglycemic Agents

Identifiers

PMID28770232
PMCPMC5523441
OpenAlexW2732474009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.